Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?
David A Jans, Kylie M Wagstaff
Cells, doi:10.3390/cells9092100
The small molecule macrocyclic lactone ivermectin, approved by the US Food and Drug Administration for parasitic infections, has received renewed attention in the last eight years due to its apparent exciting potential as an antiviral. It was identified in a high-throughput chemical screen as inhibiting recognition of the nuclear localizing Human Immunodeficiency Virus-1 (HIV-1) integrase protein by the host heterodimeric importin (IMP) α/β1 complex, and has since been shown to bind directly to IMPα to induce conformational changes that prevent its normal function in mediating nuclear import of key viral and host proteins. Excitingly, cell culture experiments show robust antiviral action towards HIV-1, dengue virus (DENV), Zika virus, West Nile virus, Venezuelan equine encephalitis virus, Chikungunya virus, Pseudorabies virus, adenovirus, and SARS-CoV-2 (COVID-19). Phase III human clinical trials have been completed for DENV, with >50 trials currently in progress worldwide for SARS-CoV-2. This mini-review discusses the case for ivermectin as a host-directed broad-spectrum antiviral agent for a range of viruses, including SARS-CoV-2.
References
Alam, Murshed, Bhiuyan, Saber, Alam et al., A Case Series of 100 COVID-19 Positive Patients Treated with Combination of Ivermectin and Doxycycline, Bangladesh Coll. Phys. Surg,
doi:10.3329/jbcps.v38i0.47512Arshad, Pertinez, Box, Tatham, Rajoli et al., Prioritisation of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived From Their Established Human Pharmacokinetics, Clin. Pharm. Ther,
doi:10.1002/cpt.1909Atkinson, Audsley, Lieu, Marsh, Thomas et al., Recognition by host nuclear transport proteins drives disorder-to-order transition in Hendra virus V, Sci. Rep,
doi:10.1038/s41598-017-18742-8Bennett, Zhao, Bosard, Imperiale, Role of a nuclear localization signal on the minor capsid proteins VP2 and VP3 in BKPyV nuclear entry, Virology,
doi:10.1016/j.virol.2014.10.013Bhatt, Gething, Brady, Messina, Farlow et al., The global distribution and burden of dengue, Nature
Boulware, Pullen, Bangdiwala, Pastick, Lofgren et al., A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19, N. Engl. J. Med,
doi:10.1056/NEJMoa2016638Brady, Gething, Bhatt, Messina, Brownstein et al., Refining the Global Spatial Limits of Dengue Virus Transmission by Evidence-Based Consensus, PLoS Negl. Trop. Dis,
doi:10.1371/journal.pntd.0001760Cao, Wang, Wen, Liu, Wang et al., A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19, N. Engl. J. Med
Changeux, Amoura, Rey, Miyara, A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications, Comptes Rendus Biol,
doi:10.5802/crbiol.8Ci, Li, Yu, Zhang, Yu et al., Avermectin exerts anti-inflammatory effect by downregulating the nuclear transcription factor kappa-B and mitogen-activated protein kinase activation pathway, Fundam. Clin. Pharmacol,
doi:10.1111/j.1472-8206.2009.00684.xCrump, Omura, Ivermectin, wonder drug from Japan: The human use perspective, Proc. Jpn. Acad,
doi:10.2183/pjab.87.13Crump, Omura, Ivermectin: Panacea for resource-poor communities?, Trends Parasitol
Foundation, The Nobel Prize in Medicine or Physiology
Fraser, Watanabe, Wang, Chan, Maher et al., A nuclear transport inhibitor that modulates the unfolded protein response and provides in vivo protection against lethal dengue virus infection, J. Infect. Dis,
doi:10.1093/infdis/jiu319Frieman, Yount, Heise, Kopecky-Bromberg, Palese et al., Severe Acute Respiratory Syndrome Coronavirus ORF6 Antagonizes STAT1 Function by Sequestering Nuclear Import Factors on the Rough Endoplasmic Reticulum/Golgi Membrane, J. Virol,
doi:10.1128/JVI.01012-07Fulcher, Jans, Regulation of nucleocytoplasmic trafficking of viral proteins; an integral role in pathogenesis ?, Biochem. Biophys. Acta Mol. Cell Res,
doi:10.1016/j.bbamcr.2011.03.019González Canga, Sahagún Prieto, Diez Liébana, Fernández Martínez, Sierra et al., The pharmacokinetics and interactions of ivermectin in humans-A mini-review, AAPSJ,
doi:10.1208/s12248-007-9000-9Gotz, Magar, Dornfeld, Giese, Pohlmann et al., Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import, Sci. Rep,
doi:10.1038/srep23138Guzzo, Furtek, Porras, Chen, Tipping et al., Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects, J. Clin. Pharmacol,
doi:10.1177/009127002401382731King, Tessier, Dodge, Weinberg, Mymryk, Lnhibition of human adenovirus replication by the importin α/β1 nuclear import inhibitor ivermectin, J. Virol,
doi:10.1128/JVI.00710-20Krause, Buisson, Bertrand, Corringer, Galzi et al., Lvermectin: A positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor, Mol. Pharmacol,
doi:10.1124/mol.53.2.283Kumar, Jeyaraman, Jain, Anudeep, A Wonder Drug in the Arsenal against COVID-19: Medication Evidence from Ivermectin, J. Adv. Med. Med. Res,
doi:10.9734/jammr/2020/v32i1030512Lopez-Denman, Russo, Wagstaff, White, Jans et al., Nucleocytoplasmic shuttling of the West Nile virus RNA-dependent RNA polymerase NS5 is critical to infection, Cell. Microbiol,
doi:10.1111/cmi.12848Loukas, Hotez, Chemotherapy of helminth infections
Lundberg, Pinkhan, Baer, Amaya, Narayan et al., Nuclear import and export inhibitors alter capsid protein distribution in mammalian cells and reduce Venezuelan Equine Encephalitis Virus replication, Antivir. Res,
doi:10.1016/j.antiviral.2013.10.004Lv, Liu, Wang, Dang, Qiu et al., Ivermectin inhibits DNA polymerase UL42 of Pseudorabies virus entrance into the nucleus and proliferation of the virus in vitro and vivo, Antivir. Res,
doi:10.1016/j.antiviral.2018.09.010Mastrangelo, Pezzullo, De Burghgraeve, Kaptein, Pastorino et al., Lvermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: New prospects for an old drug, J. Antimicrob. Chemother
Navarro, Camprubí, Requena-Méndez, Buonfrate, Giorli et al., Safety of high-dose ivermectin: A systematic review and meta-analysis, J. Antimicrob. Chemother,
doi:10.1093/jac/dkz524Porat, Effects of Gossypol on the Motility of Mammalian Sperm, Mol. Reprod. Dev
Pryor, Rawlinson, Butcher, Barton, Waterhouse et al., Nuclear localization of dengue virus nonstructural protein 5 through its importin alpha/beta-recognized nuclear localization sequences is integral to viral infection, Traffic,
doi:10.1111/j.1600-0854.2007.00579.xRahman, Iqbal, Islam, Niaz, Hussain et al., Comparison of Viral Clearance between Ivermectin with Doxycycline and Hydroxychloroquine with Azithromycin in COVID-19 Patients, Bangladesh Coll. Phys. Surg,
doi:10.3329/jbcps.v38i0.47514Schmith, Zhou, Lohmer, The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID-19, Clin. Pharm. Ther,
doi:10.1002/cpt.1889Tay, Fraser, Chan, Moreland, Rathore et al., Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin, Antivir. Res,
doi:10.1016/j.antiviral.2013.06.002Thomas, Lundberg, Pinkhan, Shechter, Debono et al., Identification of novel antivirals inhibiting recognition of Venezuelan equine encephalitis virus capsid protein by the Importin α/β1 heterodimer through high-throughput screening, Antivir. Res,
doi:10.1016/j.antiviral.2018.01.007Twum-Danso, Meredith, Variation in incidence of serious adverse events after onchocerciasis treatment with ivermectin in areas of Cameroon co-endemic for loiasis, Trop. Med. Int. Health,
doi:10.1046/j.1365-3156.2003.01091.xUs Food, Administration, FDA Cautions against Use of Hydroxychloroquine or Chloroquine for COVID-19 Outside of the Hospital Setting or a Clinical Trial due to Risk of Heart Rhythm Problems
Varghese, Kaukinen, Glaesker, Bespalov, Hanski et al., Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses, Antivir. Res,
doi:10.1016/j.antiviral.2015.12.012Wagstaff, Headey, Telwatte, Tyssen, Hearps et al., Molecular dissection of an inhibitor targeting the HIV integrase dependent preintegration complex nuclear import, Cell. Microbiol,
doi:10.1111/cmi.12953Wagstaff, Rawlinson, Hearps, Jans, An AlphaScreen(R)-based assay for high-throughput screening for specific inhibitors of nuclear import, J. Biomol. Screen,
doi:10.1177/1087057110390360Wagstaff, Sivakumaran, Heaton, Harrich, Jans, Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus, Biochem. J,
doi:10.1042/BJ20120150Wang, Zhang, Du, Du, Zhao et al., Remdesivir in adults with severe COVID-19: A randomised, double-blind, placebo-controlled, multicentre trial, Lancet,
doi:10.1016/S0140-6736(20)31022-9Yamasmith, Saleh-Arong, Avirutnan, Angkasekwinai, Mairiang et al., Efficacy and Safety of Ivermectin against Dengue Infection: A Phase III, Randomized, Double-blind, Placebo-controlled Trial
Yang, Atkinson, Fraser, Wang, Maher et al., Novel Flavivirus Antiviral That Targets The Host Nuclear Transport Importin α/β1 Heterodimer, Cells,
doi:10.3390/cells8030281Yang, Atkinson, Wang, Lee, Bogoyevitch et al., The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer, Antivir. Res,
doi:10.1016/j.antiviral.2020.104760Yang, Ye1, Zhu, Wang, Deng et al., Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets, Sci. Rep,
doi:10.1038/srep17554{ 'indexed': {'date-parts': [[2024, 5, 7]], 'date-time': '2024-05-07T11:18:41Z', 'timestamp': 1715080721755},
'reference-count': 54,
'publisher': 'MDPI AG',
'issue': '9',
'license': [ { 'start': { 'date-parts': [[2020, 9, 15]],
'date-time': '2020-09-15T00:00:00Z',
'timestamp': 1600128000000},
'content-version': 'unspecified',
'delay-in-days': 0,
'URL': 'https://creativecommons.org/licenses/by/4.0/'}],
'funder': [ { 'DOI': '10.13039/501100000925',
'name': 'National Health and Medical Research Council',
'doi-asserted-by': 'publisher',
'award': ['Senior Principal Research Fellowship APP1002486/APP1103050']}],
'content-domain': {'domain': [], 'crossmark-restriction': False},
'abstract': '<jats:p>The small molecule macrocyclic lactone ivermectin, approved by the US Food and Drug '
'Administration for parasitic infections, has received renewed attention in the last eight '
'years due to its apparent exciting potential as an antiviral. It was identified in a '
'high-throughput chemical screen as inhibiting recognition of the nuclear localizing Human '
'Immunodeficiency Virus-1 (HIV-1) integrase protein by the host heterodimeric importin (IMP) '
'α/β1 complex, and has since been shown to bind directly to IMPα to induce conformational '
'changes that prevent its normal function in mediating nuclear import of key viral and host '
'proteins. Excitingly, cell culture experiments show robust antiviral action towards HIV-1, '
'dengue virus (DENV), Zika virus, West Nile virus, Venezuelan equine encephalitis virus, '
'Chikungunya virus, Pseudorabies virus, adenovirus, and SARS-CoV-2 (COVID-19). Phase III human '
'clinical trials have been completed for DENV, with >50 trials currently in progress '
'worldwide for SARS-CoV-2. This mini-review discusses the case for ivermectin as a '
'host-directed broad-spectrum antiviral agent for a range of viruses, including '
'SARS-CoV-2.</jats:p>',
'DOI': '10.3390/cells9092100',
'type': 'journal-article',
'created': {'date-parts': [[2020, 9, 15]], 'date-time': '2020-09-15T14:24:09Z', 'timestamp': 1600179849000},
'page': '2100',
'source': 'Crossref',
'is-referenced-by-count': 52,
'title': 'Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?',
'prefix': '10.3390',
'volume': '9',
'author': [ { 'ORCID': 'http://orcid.org/0000-0001-5115-4745',
'authenticated-orcid': False,
'given': 'David A.',
'family': 'Jans',
'sequence': 'first',
'affiliation': []},
{'given': 'Kylie M.', 'family': 'Wagstaff', 'sequence': 'additional', 'affiliation': []}],
'member': '1968',
'published-online': {'date-parts': [[2020, 9, 15]]},
'reference': [ {'key': 'ref1', 'doi-asserted-by': 'publisher', 'DOI': '10.2183/pjab.87.13'},
{ 'key': 'ref2',
'unstructured': 'The Nobel Prize in Medicine or '
'Physiologyhttps://www.nobelprize.org/prizes/medicine/2015/press-release'},
{'key': 'ref3', 'doi-asserted-by': 'publisher', 'DOI': '10.1208/s12248-007-9000-9'},
{ 'key': 'ref4',
'doi-asserted-by': 'crossref',
'first-page': '445',
'DOI': '10.1016/j.pt.2014.07.005',
'article-title': 'Ivermectin: Panacea for resource-poor communities?',
'volume': '30',
'author': 'Crump',
'year': '2014',
'journal-title': 'Trends Parasitol.'},
{ 'key': 'ref5',
'unstructured': 'World Health Organization’s List of Essential Medicines 21st List '
'2019https://apps.who.int/iris/bitstream/handle/10665/325771/WHO-MVP-EMP-IAU-2019.06-eng.pdf'},
{'key': 'ref6', 'doi-asserted-by': 'publisher', 'DOI': '10.9734/jammr/2020/v32i1030512'},
{'key': 'ref7', 'doi-asserted-by': 'publisher', 'DOI': '10.1042/BJ20120150'},
{'key': 'ref8', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.antiviral.2013.06.002'},
{'key': 'ref9', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.antiviral.2013.10.004'},
{'key': 'ref10', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/srep23138'},
{'key': 'ref11', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.antiviral.2020.104760'},
{'key': 'ref12', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/jac/dks147'},
{'key': 'ref13', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41598-017-18742-8'},
{'key': 'ref14', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.ceb.2019.01.001'},
{'key': 'ref15', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.antiviral.2015.12.012'},
{'key': 'ref16', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.antiviral.2018.01.007'},
{'key': 'ref17', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.antiviral.2020.104787'},
{'key': 'ref18', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.antiviral.2018.09.010'},
{'key': 'ref19', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.virol.2014.10.013'},
{'key': 'ref20', 'doi-asserted-by': 'publisher', 'DOI': '10.1128/JVI.00710-20'},
{'key': 'ref21', 'doi-asserted-by': 'publisher', 'DOI': '10.5802/crbiol.8'},
{'key': 'ref22', 'doi-asserted-by': 'publisher', 'DOI': '10.1124/mol.53.2.283'},
{'key': 'ref23', 'doi-asserted-by': 'publisher', 'DOI': '10.1177/009127002401382731'},
{ 'key': 'ref24',
'series-title': 'Goodman & Gilman’s The Pharmacological Basis of Therapeutics',
'first-page': '1073',
'article-title': 'Chemotherapy of helminth infections',
'author': 'Loukas',
'year': '2006'},
{'key': 'ref25', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/jac/dkz524'},
{'key': 'ref26', 'doi-asserted-by': 'publisher', 'DOI': '10.1046/j.1365-3156.2003.01091.x'},
{'key': 'ref27', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.bbamcr.2011.03.019'},
{'key': 'ref28', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.antiviral.2012.06.008'},
{'key': 'ref29', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/cells8030281'},
{'key': 'ref30', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/j.1600-0854.2007.00579.x'},
{'key': 'ref31', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/infdis/jiu319'},
{'key': 'ref32', 'doi-asserted-by': 'publisher', 'DOI': '10.1128/JVI.01012-07'},
{'key': 'ref33', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/srep17554'},
{'key': 'ref34', 'doi-asserted-by': 'publisher', 'DOI': '10.1177/1087057110390360'},
{'key': 'ref35', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/cmi.12953'},
{'key': 'ref36', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/cmi.12848'},
{'key': 'ref37', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/j.1472-8206.2009.00684.x'},
{'key': 'ref38', 'doi-asserted-by': 'publisher', 'DOI': '10.1046/j.1365-2605.1998.00091.x'},
{'key': 'ref39', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/mrd.1080250414'},
{'key': 'ref40'},
{'key': 'ref41', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/nature12060'},
{'key': 'ref42', 'doi-asserted-by': 'publisher', 'DOI': '10.1371/journal.pntd.0001760'},
{'key': 'ref43', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/NEJMoa2016638'},
{'key': 'ref44'}, {'key': 'ref45'},
{'key': 'ref46', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/NEJMoa2001282'},
{'key': 'ref47', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/S0140-6736(20)31022-9'},
{'key': 'ref48', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/cpt.1909'},
{'key': 'ref49', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/cpt.1889'},
{ 'key': 'ref50',
'unstructured': 'Eurnekian Public Hospital Argentina’s IVERCAR Ivermectin & Carrageenan '
'Study Shows Positive Results Targeting '
'COVID-19https://www.trialsitenews.com/argentinas-ivercar-ivermectin-carrageenan-study-shows-positive-results-targeting-covid-19/'},
{'key': 'ref51', 'doi-asserted-by': 'publisher', 'DOI': '10.3329/jbcps.v38i0.47512'},
{'key': 'ref52', 'doi-asserted-by': 'publisher', 'DOI': '10.3329/jbcps.v38i0.47514'},
{ 'key': 'ref53',
'unstructured': 'RM_270-2020-MINSAhttps://cdn.www.gob.pe/uploads/document/file/694719/RM_270-2020-MINSA.PDF'},
{ 'key': 'ref54',
'unstructured': 'Ministerial Resolution No 259 from the Gobierno del Estate Plurinacional '
'de Bolivia Misterio de '
'Saludhttps://www.minsalud.gob.bo/component/jdownloads/send/27-comunicado-oficial/425-resolucion-ministerial-n-0259'}],
'container-title': 'Cells',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://www.mdpi.com/2073-4409/9/9/2100/pdf',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2020, 9, 16]],
'date-time': '2020-09-16T00:29:09Z',
'timestamp': 1600216149000},
'score': 1,
'resource': {'primary': {'URL': 'https://www.mdpi.com/2073-4409/9/9/2100'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2020, 9, 15]]},
'references-count': 54,
'journal-issue': {'issue': '9', 'published-online': {'date-parts': [[2020, 9]]}},
'alternative-id': ['cells9092100'],
'URL': 'http://dx.doi.org/10.3390/cells9092100',
'relation': {},
'ISSN': ['2073-4409'],
'subject': [],
'container-title-short': 'Cells',
'published': {'date-parts': [[2020, 9, 15]]}}
